Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Cancer Res. 2019 Feb 13;79(7):1696–1704. doi: 10.1158/0008-5472.CAN-18-3837

Figure 3:

Figure 3:

Kaplan-Meier survival plots show significantly worse survival in patients with tumors exhibiting low 18F-fluorocholine (FCH) uptake versus patients with tumors exhibiting high FCH uptake (median survival > 1000 days vs. 690 days, p = 0.031).

HHS Vulnerability Disclosure